Tilray Inc (NASDAQ:TLRY) Stake Lowered by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp decreased its stake in Tilray Inc (NASDAQ:TLRY) by 6.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 453,091 shares of the company’s stock after selling 30,975 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Tilray were worth $752,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Bank of Montreal Can boosted its holdings in shares of Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after acquiring an additional 355,778 shares during the period. Marathon Trading Investment Management LLC raised its holdings in shares of Tilray by 52.4% during the second quarter. Marathon Trading Investment Management LLC now owns 76,501 shares of the company’s stock valued at $127,000 after buying an additional 26,301 shares during the last quarter. WINTON GROUP Ltd acquired a new position in shares of Tilray during the second quarter worth approximately $83,000. J.W. Cole Advisors Inc. grew its holdings in Tilray by 1,077.2% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock worth $284,000 after buying an additional 156,524 shares in the last quarter. Finally, Vanguard Capital Wealth Advisors acquired a new stake in Tilray in the 2nd quarter valued at approximately $34,000. Institutional investors own 9.35% of the company’s stock.

Tilray Price Performance

Shares of Tilray stock opened at $1.74 on Monday. Tilray Inc has a 1-year low of $1.50 and a 1-year high of $2.97. The company has a market capitalization of $1.47 billion, a P/E ratio of -3.95 and a beta of 2.13. The business’s fifty day moving average price is $1.80 and its two-hundred day moving average price is $1.88. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business’s revenue for the quarter was up 24.8% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.15) EPS. As a group, research analysts forecast that Tilray Inc will post -0.16 EPS for the current year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.